Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 591.42
-0.58 (-0.10%)
At close: Apr 24, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 48.46 billion as of April 25, 2025. Its market cap has decreased by -39.47% in one year.
Market Cap
48.46B
Enterprise Value
37.21B
Revenue
11.34B
Ranking
n/a
PE Ratio
13.75
Stock Price
591.42
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 48.46B, an increase of 50,314.14%. That is a compound annual growth rate of 20.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.23B |
| GSK plc | 55.19B |
| Haleon | 34.87B |
| Smith & Nephew | 8.58B |
| ConvaTec Group | 5.21B |
| Hikma Pharmaceuticals | 4.15B |
| HUTCHMED (China) | 2.01B |
| Oxford Nanopore Technologies | 1.13B |